Hatch-Waxman filing in Delaware surged 60% in 2017
Hatch-Waxman pharma patent litigation filings last year rose to near-2015 levels. Lex Machina’s new ANDA litigation report also reveals data on judges, plaintiffs, defendants and law firms
Lex Machina’s Hatch-Waxman ANDA Litigation
report reveals the number of pharmaceutical patent cases
filed in district court rebounded to 417 filings in 2017 from
324 filings in 2016 – coming up on 2015’s
high of 475 filings.
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.